Technology Developments and New Clinical Applications to Steer Growth in the Global Imaging Agents Market, According to New Report by Global Industry Analysts, Inc.

Share Article

GIA announces the release of a comprehensive global report on Imaging Agents market. The medical imaging market is expected to witness steady growth driven by developments in technology and new clinical applications. Rising number of installed imaging equipment worldwide, particularly in developing markets is also driving the demand for contrast agents. Development of targeted agents is expected to further accelerate market growth.

Imaging Agents: A Global Strategic Business Report

Follow us on LinkedIn – Effervescent technology developments over the last two decades have expanded the application roles of imaging agents. The hitherto quite and underrated market hit the limelight with technology breakthroughs documenting their evolution from the uncomplicated use of barium sulfate slurry to enhance medical images to cutting edge monoclonal antibodies to identify tumor markers. Global imaging agent market is also expected to witness progressive change if targeted MRI and ultrasound imaging, a technology currently under developmental stage, comes to fruition. The technology could make imaging a definitive procedure for detection of cardiovascular ailments as well as tumors. Spurred by expansion of imaging modalities in new clinical applications and technological advancements, the Imaging Agents segment is expected to achieve significant growth rates in future. Demand for imaging agents is in tandem with diagnosis and management of several age-related diseases including cardiovascular disease, cancer, and neurological disease. Prevalence of these diseases has augmented in recent years with increase in percentage of senior population worldwide. Emerging application trends in the healthcare market include whole body screening, therapeutic monitoring, and guided therapeutic interventions. Contrast agents are facilitating in expansion of imaging's function in basic research as well as drug development/discovery.

As stated by the new market research report on Imaging Agents, the US continues to remain the largest regional market. With a host of international majors operating in the market, the country represents an intensely competitive market for new players. Developing countries, specifically in the Asia-Pacific region are considered the budding grounds for growth in the imaging agents market, particularly in light of commendable economic growth. The impact of the global economic meltdown on BRIC countries has been limited, allowing governments to continue focusing on the implementation of long-term initiatives aimed at improving healthcare infrastructure. While Russia’s focus has been on renewal of existing equipment, Brazil, China and India are focusing efforts on improving access to quality healthcare, particularly in rural areas and smaller towns and cities. Firms are increasingly focusing on expansion in developing markets of Asia, Latin America and Eastern Europe where private financing sectors are likely to raise investment capital.

X-ray contrast media, which dominated the market, is slowly losing luster, paving way for emerging segments. The segment is witnessing a rapid decline in mature markets and is displaying decelerated growth in developing regions. The global ultrasound contrast media market provides enormous potential, as the segment continues to enhance the usefulness of diagnostic ultrasound scans and procedures. Radiopharmaceuticals is expected to find attractive business opportunities in the area of nuclear medicine. In diagnosis, nuclear medicine involves the use of tiny amounts of radiopharmaceuticals, which are essentially radioactive materials designed to emit gamma rays that can be detected and picked up by imaging cameras.

Major players in the marketplace include AMAG Pharmaceuticals Inc, GE Healthcare, Bayer Schering Pharma AG, Covidien, Bayer HealthCare Pharmaceuticals, Bracco Group, Daiichi Sankyo Company Limited, Eisai Co Ltd., Guerbet Group, and Lantheus Medical Imaging.

The research report titled "Imaging Agents: A Global Strategic Business Report" announced by Global Industry Analysts, Inc., provides a comprehensive review of trends, issues, strategic industry activities, and profiles of major companies worldwide. The report provides market estimates and projections (US$ Million) for product segments Contrast Media (X-ray imaging agents, MRI imaging agents and Ultrasound imaging agents) and Diagnostic Radiopharmaceuticals. Analysis is presented for major geographic markets including United States, Japan, France, Germany, the UK, Italy, Asia, Latin America and the Middle East.

For more details about this comprehensive market research report, please visit –
http://www.strategyr.com/Imaging_Agents_Market_Report.asp

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.

Follow us on LinkedIn

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site: http://www.StrategyR.com/

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Public Relations
Visit website